Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Samuel D Moscavitch"'
Autor:
Ayodeji Awoyemi, Cristiane Mayerhofer, Alex S Felix, Johannes R Hov, Samuel D Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K Berge, Simen H Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch
Publikováno v:
EBioMedicine, Vol 70, Iss , Pp 103511- (2021)
Background: The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast Saccharomyces boulardii hav
Externí odkaz:
https://doaj.org/article/7a3b3ad0db934ab9973249e4de4fc5e4
Publikováno v:
ABC: Heart Failure & Cardiomyopathy. 1:1-10
Why COVID-19 became an issue for cardiovascular specialists? SARS-CoV-2- related myocardial injury and myocarditis Approximately 20-30% of hospitalized patients with COVID-19 have evidence of cardiac injury, as indicated by elevated levels of high-se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ff84a0894b0f1c9249061ca5d69c8ae
https://doi.org/10.36660/abchf.20210001
https://doi.org/10.36660/abchf.20210001
Autor:
Sandra M. Miranda, Samuel D. Moscavitch, Larissa R. Carestiato, Renata M. Felix, Ronaldo C. Rodrigues, Leandro R. Messias, Jader C. Azevedo, Antonio Cláudio L. Nóbrega, Evandro Tinoco Mesquita, Claudio Tinoco Mesquita
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 101, Iss 1, Pp 4-8 (2013)
FUNDAMENTO: A associação da ativação autonômica, fração de ejeção do ventrículo esquerdo (FEVE) e classe funcional da insuficiência cardíaca é mal compreendida. Objetivo: Nosso objetivo foi correlacionar a gravidade dos sintomas com a at
Externí odkaz:
https://doaj.org/article/badc9f9723ef4e9aa4f3928005a7635f
Autor:
Shah Kavi, Peter Libby, Tetsushi Nakao, Rob S. Sellar, Paul Carter, M. J. Gomes, Samuel D. Moscavitch, Yevgenia Tesmenitsky, Eugenia Shvartz, Marie McConkey, Victoria Ruvkun, Eva Kritikou, Shamsudheen K. Vellarikkal, Galina K. Sukhova, Waihay J. Wong, Benjamin L. Ebert, Andrew H. Lichtman, Amelie Vromman, Grasiele Sausen, Rajat M. Gupta
Publikováno v:
Circulation. 142
Introduction: Clonal hematopoiesis of indeterminate potential (CHIP) describes somatic mutations of bone marrow derived blood cells in the absence of overt hematological disease. CHIP correlates with aging and atherosclerotic cardiovascular diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29b46214f176f5be6774b7593f633384
https://doi.org/10.1161/circ.142.suppl_3.15355
https://doi.org/10.1161/circ.142.suppl_3.15355
Autor:
Samuel D. Moscavitch, Kaspar Broch, Sigrun Halvorsen, Lars Gullestad, Marius Trøseid, Christiane Caroline Mayerhofer, Andrea De Lorenzo, Pål Aukrust, Ingebjørg Seljeflot, Anders Hovland, Johannes R. Hov, Knut Tore Lappegård, Ayodeji Awoyemi
Publikováno v:
ESC Heart Failure. 5:977-984
AIMS Heart failure (HF) is a multifactorial disease. Current treatments target only a fraction of the putative pathophysiological pathways. In patients with HF, reduced cardiac output and congestion cause increased gut wall permeability. It has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ee03227663fcd93c32f9d941cb36f4c
https://doi.org/10.1002/ehf2.12332
https://doi.org/10.1002/ehf2.12332
Autor:
Cristiane C.K. Mayerhofer, Svein Solheim, Anders Hovland, Samuel D. Moscavitch, Bente Halvorsen, Kaspar Broch, Johannes R. Hov, Rolf K. Berge, Asbjørn Svardal, Ingebjørg Seljeflot, Kristian Holm, Andrea De Lorenzo, Simen Hyll Hansen, Sigrun Halvorsen, Ida Gregersen, Alexandra Götz, Ayodeji Awoyemi, Knut Tore Lappegård, Lars Gullestad, Alex dos Santos Felix, Pål Aukrust, Sissel Åkra, Marius Trøseid
Publikováno v:
EBioMedicine, Vol 70, Iss, Pp 103511-(2021)
EBioMedicine
EBioMedicine
Background: The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast Saccharomyces boulardii hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7aa42c21f49094d0a40c962a31a68b6
https://doi.org/10.1016/j.ebiom.2021.103511
https://doi.org/10.1016/j.ebiom.2021.103511
Autor:
Evandro Tinoco Mesquita, Annelise C. Costanza, Hugo Caire de Castro Faria Neto, Samuel D. Moscavitch
Publikováno v:
International Journal of Cardiology. 179:348-350
On the last decade, there has been a progressive increase in a number of publications on microbiota and therapeutic potential of probiotics. Recent studies have been suggesting that consuming probiotics may have benefits on cardiovascular system, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055043da7270f9dcb2c0583967a51154
https://doi.org/10.1016/j.ijcard.2014.11.034
https://doi.org/10.1016/j.ijcard.2014.11.034
Publikováno v:
The Israel Medical Association journal : IMAJ. 10(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46ce17c61c38265cd80ae51e0321b6eb
https://pubmed.ncbi.nlm.nih.gov/18751643
https://pubmed.ncbi.nlm.nih.gov/18751643